Class I defensin, NaD2

General Information


DRACP ID  DRACP00610

Peptide Name   Class I defensin, NaD2

Sequence  RTCESQSHRFKGPCARDSNCATVCLTEGFSGGDCRGFRRRCFCTRPC

Sequence Length  47

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
U-937 Adult acute monocytic leukemi; Acute monoblastic/monocytic leukemia Leukemia 5.9±1.3% Cell death=10 µM PI uptake assay 30min 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00610

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Cys23<--->Cys47; Cys14<---Cys34; Cys20<--->Cys41; Cys24<--->Cys43

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C212H338N76O66S8

Absent amino acids  IMWY

Common amino acids  CR

Mass  608462

Pl  8.61

Basic residues  10

Acidic residues  4

Hydrophobic residues  8

Net charge  6

Boman Index  -15725

Hydrophobicity  -69.15

Aliphatic Index  18.72

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  500

Absorbance 280nm  10.87

Polar residues  22

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 27503651

Title  Nicotiana alata Defensin Chimeras Reveal Differences in the Mechanism of Fungal and Tumor Cell Killing and an Enhanced Antifungal Variant

Doi 10.1128/AAC.01479-16

Year  2016

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.